Yatırımcı.AI

BISTTRYOct 7, 18:19Live

Nasmed Özel Sağlık Hizmetleri Ticaret A.Ş.

EGEPO Ratio Analysis: P/E, P/B, EV/EBITDANasmed Özel Sağlık Hizmetleri Ticaret A.Ş.

Main MarketEducation, Health, Sports and Social Services
5.62−0.52 (−8.47%)
Volume
TRY 59.4M
Day range
5.53 – 6.30
Previous close
6.14
Market cap
TRY 2.8B

Last updated: Source: Borsa Istanbul, 15-minute delayed

35 key ratios for Nasmed Özel Sağlık Hizmetleri Ticaret A.Ş. (EGEPO) computed from the latest financial statements and the current price: valuation, profitability, liquidity, leverage and efficiency.

Ratio Analysis

P/E—
P/B1.30
EV/EBITDA10.90
Dividend yield—
Beta—
Earnings per share−0.1 TL
Book value per share4.3 TL
EBITDA148.4M TL
Net profit−61.6M TL
Operating profit51.1M TL
Operating profit before finance costs53.2M TL
Net working capital247.3M TL
Gross margin14.33%
Operating margin5.34%
Net margin−6.44%
Return on assets−2.31%
Return on equity−2.87%
Current ratio1.85
Quick ratio1.80
Cash ratio—
Leverage ratio21.06
Debt to equity0.27
Debt to assets0.21
Fixed assets to equity1.02
Short-term debt share0.06
Interest coverage—
Receivables turnover0.56
Days sales outstanding652
Inventory turnover56.75
Days inventory outstanding6
Payables turnover7.99
Days payables outstanding46
Working capital turnover3.87
Equity turnover0.44
Asset turnover0.35

Frequently Asked Questions

EGEPO has a P/B ratio of 1.30 and an EV/EBITDA of 10.90.

Price-based ratios (P/E, P/B, EV/EBITDA, dividend yield) refresh daily; balance-sheet ratios refresh after the company publishes its KAP financial report.